Tumor markers in the ovarian carcinoma
Margariti, P.A.; Benedetti Panici, P.; Villani, L.; Di Roberto, P.; Maiorca, A.; Sacco, F.; Bompiani, A.
European Journal of Gynaecological Oncology 1(2): 77-79
1980
ISSN/ISBN: 0392-2936 PMID: 6174341 Document Number: 155906
Document emailed within 1 workday
Related Documents
Nozawa, S.; Udagawa, Y.; Sasaki, H.; Ito, K.; Akiya, K.; Terashima, Y.; Takamizawa, H.; Ohkura, H.; Fujimoto, S.; Hashimoto, M. 1992: Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 2085-2093Xu, S.X. 1990: Tumor markers in the monitoring of ovarian cancer Zhonghua Fu Chan Ke Za Zhi 25(6): 345-347; 383
Gramellini, D.; Rutolo, S.; Verrotti, C.; Piantelli, G.; Fieni, S.; Vadora, E. 2001: Sonographic characterization, Doppler ultrasonography and tumor markers in the diagnosis of malignancy of ovarian masses Minerva Ginecologica 53(1): 1-11
Yamauchi, M.; Yoshigoe, F.; Mera, F.; Ogura, K.; Kameda, H.; Nakada, J.; Takasaka, S.; Machida, T.; Fukunaga, M. 1983: An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers Gan no Rinsho. Japan Journal of Cancer Clinics 29(4): a
Katsaros, D.; Fracchioli, S.; Arts, H.J.; de Vries, E.G.; Danese, S.; Richiardi, G.; Arisio, R.; Gordini, G.; Van der Zee, A.G.; Suurmeijer, A.J.; Massobrio, M. 1999: Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma Minerva Ginecologica 51(12): 463-470
Kubo, S.; Matsukawa, M. 2004: Tumor markers of hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(13): 2203-2206
Hou, J.-X.; Yang, X.-Q.; Chen, C.; Jiang, Q.; Yang, G.-L.; Li, Y. 2011: Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis Hepato-Gastroenterology 58(106): 632-636
Cottini, M.; Carnino, F.; Iskra, L.; Rapisarda, V.; Mossetti, C. 1986: Tumor markers in epithelial carcinoma of the ovary Minerva Ginecologica 38(6): 479-484
Higaki, Y.; Imamura, K. 1989: Changes in tumor markers following cryosurgery of prostate carcinoma Hinyokika Kiyo. Acta Urologica Japonica 35(2): 265-270
Crombach, G. 1998: Considerations in rational use of tumor markers in breast carcinoma Praxis 87(17): 589-594
Lipská, L.; Visokai, V.; Levý, M.; Svobodová, Sárka.; Kormunda, S.; Fínek, J. 2007: Tumor markers in patients with relapse of colorectal carcinoma Anticancer Research 27(4a): 1901-1905
Kang, S.; Shen, K.; Lang, J. 1998: The comparison of biological characteristics between tumor-infiltrating lymphocytes and tumor-associated lymphocytes in ascites of epithelial ovarian carcinoma Zhonghua Fu Chan Ke Za Zhi 33(10): 607-610
Mahler, B. 2008: Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma Pneumologia 57(3): 175-177
de Oliveira e Silva, A.; Roldan-Molina, F.; dos Santos, T.E.; Santo, G.C.; Miranda, M.P.; Genzini, T.; Neves, L.B.; D'Albuquerque, L.A. 1990: Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers Arquivos de Gastroenterologia 27(2): 83-94
Thomas, C.M.; Wobbes, T.; Bonfrer, J.M.; Peterse, J.L.; Nap, M.; Beex, L.V. 1993: Tumor markers in screening, diagnosis and treatment of patients with breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 137(46): 2354-2357
Schneider, J.; Barbazan, M.; Centeno, M.; Montoya, F.; Neyro, J.L.; Rodriguez-Escudero, F.J. 1991: Tumor recurrence following negative second-look laparotomy in ovarian carcinoma Zentralblatt für Gynakologie 113(22): 1246-1250
Marth, C.; Fuith, L.C.; Böck, G.; Daxenbichler, G.; Dapunt, O. 1989: Modulation of ovarian carcinoma tumor marker CA-125 by gamma-interferon Cancer Research 49(23): 6538-6542
Hiura, M.; Yorishima, M.; Tanaka, M.; Yokoyama, T.; Myoga, H.; Chiba, T.; Nakanishi, Y. 1990: A clinical study on multiple tumor markers following therapy in patients with uterine cervical carcinoma Nihon Sanka Fujinka Gakkai Zasshi 42(5): 471-478
Vardi, J.R.; Tadros, G.H.; Zamurovic, D.; Rafla, S.D. 1992: Tumor debulking followed by immediate combination chemotherapy in advanced ovarian carcinoma. Phase II Acta Obstetricia et Gynecologica Scandinavica 71(5): 361-367
Takeyama, H.; Wakamiya, N.; O'Hara, C.; Arthur, K.; Niloff, J.; Kufe, D.; Sakarai, K.; Spriggs, D. 1991: Tumor necrosis factor expression by human ovarian carcinoma in vivo Cancer Research 51(16): 4476-4480